Quantum BioPharma Ltd.

QNTM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$14,916-$18,231-$26,704-$33,938
Dep. & Amort.$491$2,506$4,535$4,046
Deferred Tax$0$0$0$0
Stock-Based Comp.$152$3,835$1,531$7,444
Change in WC$9,757$1,638-$7,120$2,889
Other Non-Cash-$2,360-$576-$575-$1,186
Operating Cash Flow-$6,876-$10,827-$28,333-$20,746
Investing Activities
PP&E Inv.$0$0-$114-$500
Net Acquisitions$0$32$0$769
Inv. Purchases-$7,693-$745-$402$0
Inv. Sales/Matur.$6,189$443$12,889$0
Other Inv. Act.$0$0-$250$0
Investing Cash Flow-$1,504-$270$12,123$269
Financing Activities
Debt Repay.$948-$189-$143-$129
Stock Issued$10,671$0$0$38,341
Stock Repurch.$0-$2,958-$1,926$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$20$0$0
Financing Cash Flow$11,619-$3,127-$2,069$38,212
Forex Effect$0$0$0$0
Net Chg. in Cash$3,239-$14,223-$18,279$17,735
Supplemental Information
Beg. Cash$2,757$16,980$35,260$17,525
End Cash$5,996$2,757$16,980$35,260
Free Cash Flow-$6,876-$10,827-$28,697-$21,246
Quantum BioPharma Ltd. (QNTM) Financial Statements & Key Stats | AlphaPilot